Tolosa E - Search Results

1

Cerebrospinal fluid biomarkers and clinical features in leucine-rich repeat kinase 2 (LRRK2) mutation carriers.

Vilas D, Shaw LM, Taylor P, Berg D, Brockmann K, Aasly J, Marras C, Pont-Sunyer C, Ríos J, Marek K, Tolosa E. Vilas D, et al. Among authors: tolosa e. Mov Disord. 2016 Jun;31(6):906-14. doi: 10.1002/mds.26591. Epub 2016 Apr 4. Mov Disord. 2016. PMID: 27041685

2

Further extension of the H1 haplotype associated with progressive supranuclear palsy.

Pastor P, Ezquerra M, Tolosa E, Muñoz E, Martí MJ, Valldeoriola F, Molinuevo JL, Calopa M, Oliva R. Pastor P, et al. Among authors: tolosa e. Mov Disord. 2002 May;17(3):550-6. doi: 10.1002/mds.10076. Mov Disord. 2002. PMID: 12112206

3

Clinical overview of the synucleinopathies.

Martí MJ, Tolosa E, Campdelacreu J. Martí MJ, et al. Among authors: tolosa e. Mov Disord. 2003 Sep;18 Suppl 6:S21-7. doi: 10.1002/mds.10559. Mov Disord. 2003. PMID: 14502652 Review.

4

DAT imaging in drug-induced and psychogenic parkinsonism.

Tolosa E, Coelho M, Gallardo M. Tolosa E, et al. Mov Disord. 2003 Oct;18 Suppl 7:S28-33. doi: 10.1002/mds.10575. Mov Disord. 2003. PMID: 14531043 Review.

5

Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease.

Alegret M, Valldeoriola F, Martí M, Pilleri M, Junqué C, Rumià J, Tolosa E. Alegret M, et al. Among authors: tolosa e. Mov Disord. 2004 Dec;19(12):1463-9. doi: 10.1002/mds.20237. Mov Disord. 2004. PMID: 15390065

6

LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance.

Gaig C, Ezquerra M, Marti MJ, Muñoz E, Valldeoriola F, Tolosa E. Gaig C, et al. Among authors: tolosa e. Arch Neurol. 2006 Mar;63(3):377-82. doi: 10.1001/archneur.63.3.377. Arch Neurol. 2006. PMID: 16533964

7

Neuropsychological deficits in Parkinson's disease patients with visual hallucinations.

Ramírez-Ruiz B, Junqué C, Martí MJ, Valldeoriola F, Tolosa E. Ramírez-Ruiz B, et al. Among authors: tolosa e. Mov Disord. 2006 Sep;21(9):1483-7. doi: 10.1002/mds.20965. Mov Disord. 2006. PMID: 16705661

8

123I-Ioflupane SPECT in the diagnosis of suspected psychogenic Parkinsonism.

Gaig C, Martí MJ, Tolosa E, Valldeoriola F, Paredes P, Lomeña FJ, Nakamae F. Gaig C, et al. Among authors: tolosa e. Mov Disord. 2006 Nov;21(11):1994-8. doi: 10.1002/mds.21062. Mov Disord. 2006. PMID: 16941463

9

G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies.

Gaig C, Martí MJ, Ezquerra M, Rey MJ, Cardozo A, Tolosa E. Gaig C, et al. Among authors: tolosa e. J Neurol Neurosurg Psychiatry. 2007 Jun;78(6):626-8. doi: 10.1136/jnnp.2006.107904. Epub 2007 Jan 8. J Neurol Neurosurg Psychiatry. 2007. PMID: 17210620 Free PMC article.

10

Eating-induced facial myoclonic dystonia probably due to a putaminal lesion.

Gaig C, Muñoz E, Valls-Solé J, Martí MJ, Tolosa E. Gaig C, et al. Among authors: tolosa e. Mov Disord. 2007 Apr 30;22(6):877-80. doi: 10.1002/mds.21345. Mov Disord. 2007. PMID: 17290449

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

920 results

Search Page

Filters